A systematic review on durability and structural valve deterioration in TAVR and surgical AVR

References

• Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2017;52(3):408–417.
   PubMed Web of Science ®Google Scholar
• Cartlidge TRG, Doris MK, Sellers SL, et al. Detection and prediction of bioprosthetic aortic valve degeneration. J Am Coll Cardiol. 2019;73(10):1107–1119.
   Web of Science ®Google Scholar
• Wang M, Furnary AP, Li HF, et al. Bioprosthetic aortic valve durability: a meta-regression of published studies. Ann Thorac Surg. 2017;104(3):1080–1087.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al.; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–1454.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–1798.
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al.; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al.; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019; 380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al.; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Petronio AS, Ettori F, et al. 5-year outcomes after transcatheter aortic valve implantation with corevalve prosthesis. JACC Cardiovasc Interv. 2015;8(8):1084–1091.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2485–2491.
   PubMed Web of Science ®Google Scholar
• Dvir D, Bourguignon T, Otto CM, et al.; VIVID (Valve in Valve International Data) Investigators. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137(4):388–399.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gabella T, Voisine P, Puri R, et al. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017;70(8):1013–1028.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gabella T, Voisine P, Dagenais F, et al. Long-Term Outcomes Following Surgical Aortic Bioprosthesis Implantation. J Am Coll Cardiol. 2018; 71(13):1401–1412.
   Web of Science ®Google Scholar
• Capodanno D, Sondergaard L, Tamburino C. Durability of transcatheter bioprosthetic aortic valves: the story so far. EuroIntervention. 2019;15(10):846–849.
   Web of Science ®Google Scholar
• Senage T, Le Tourneau T, Foucher Y, et al. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation. 2014;130(23):2012–2020.
   PubMed Web of Science ®Google Scholar
• Mahjoub H, Mathieu P, Senechal M, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol. 2013;61(7):752–761.
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32(2):205–217.
   PubMed Web of Science ®Google Scholar
• Bagur R, Pibarot P, Otto CM. Importance of the valve durability-life expectancy ratio in selection of a prosthetic aortic valve. Heart. 2017;103(22):1756–1759.
   Web of Science ®Google Scholar
• Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg. 2015;99(3):831–837.
   PubMed Web of Science ®Google Scholar
• David TE, Armstrong S, Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg. 2010;90(3):775–781.
   PubMed Web of Science ®Google Scholar
• Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99(4):1239–1247.
   PubMed Web of Science ®Google Scholar
• Forcillo J, El Hamamsy I, Stevens LM, et al. The perimount valve in the aortic position: twenty-year experience with patients under 60 years old. Ann Thorac Surg. 2014;97(5):1526–1532.
   PubMed Web of Science ®Google Scholar
• Konakci KZ, Bohle B, Blumer R, et al. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest. 2005;35(1):17–23.
   PubMed Web of Science ®Google Scholar
• Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol. 2016;13(6):360–367.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Jama. 2014;311(15):1503–1514.
   PubMed Web of Science ®Google Scholar
• Del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67(6):644–655.
   Web of Science ®Google Scholar
• Glaser N, Jackson V, Franco-Cereceda A, et al. Survival after aortic valve replacement with bovine or porcine valve prostheses: a systematic review and meta-analysis. Thorac Cardiovasc Surg. 2019;67(4):282–290.
   Web of Science ®Google Scholar
• Paradis JM, Del Trigo M, Puri R, et al. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol. 2015;66(18):2019–2037.
   PubMed Web of Science ®Google Scholar
• Binder RK, Nietlispach F, Holubec T, et al. Percutaneous treatment of severe transvalvular and paravalvular regurgitation in a failing surgical aortic valve prosthesis due to recurrent endocarditis. Eur Heart J. 2016;37(45):3419.
   Web of Science ®Google Scholar
• Jilaihawi H, Asch FM, Manasse E, et al. Systematic CT methodology for the evaluation of subclinical leaflet thrombosis. JACC Cardiovasc Imaging. 2017;10(4):461–470.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015–2024.
   PubMed Web of Science ®Google Scholar
• Salaun E, Cote N, Clavel MA, et al. Biomarkers of aortic bioprosthetic valve structural degeneration. Curr Opin Cardiol. 2019;34(2):132–139.
   PubMed Web of Science ®Google Scholar
• Repossini A, Fischlein T, Santarpino G, et al. Pericardial Stentless Valve for Aortic Valve Replacement: Long-Term Results. Ann Thorac Surg. 2016;102(6):1956–1965. doi:https://doi.org/10.1016/j.athoracsur.2016.05.080. 27544291
   Web of Science ®Google Scholar
• Guenzinger R, Fiegl K, Wottke M, et al. Twenty-Seven-Year Experience With the St. Jude Medical Biocor Bioprosthesis in the Aortic Position. The Annals of Thoracic Surgery. 2015;100(6):2220–2226. doi:https://doi.org/10.1016/j.athoracsur.2015.06.027.
   Web of Science ®Google Scholar
• Bourguignon T, El Khoury R, Candolfi P, et al. Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger. The Annals of Thoracic Surgery. 2015;100(3):853–859. doi:https://doi.org/10.1016/j.athoracsur.2015.03.105.
   PubMed Web of Science ®Google Scholar
• Christ T, Claus B, Borck R, et al. The St. Jude Toronto stentless bioprosthesis: Up to 20 years follow-up in younger patients. HSF. 2015;18(4):129 doi:https://doi.org/10.1532/hsf.1252.
   Web of Science ®Google Scholar
• Bach D S, Kon N D. Long-Term Clinical Outcomes 15 Years After Aortic Valve Replacement With the Freestyle Stentless Aortic Bioprosthesis. The Annals of Thoracic Surgery. 2014;97(2):544–551. doi:https://doi.org/10.1016/j.athoracsur.2013.08.047.
   Web of Science ®Google Scholar
• Forcillo J, Pellerin M, Perrault LP, et al. Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg. 2013;96(2):486–493.
   Web of Science ®Google Scholar
• Mohammadi S, Tchana-Sato V, Kalavrouziotis D, et al. Long-Term Clinical and Echocardiographic Follow-Up of the Freestyle Stentless Aortic Bioprosthesis. Circulation. 2012;126(11_suppl_1):S198–S204. doi:https://doi.org/10.1161/CIRCULATIONAHA.111.084806.
   Web of Science ®Google Scholar
• Mykén P S U, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137(1):76–81. doi:https://doi.org/10.1016/j.jtcvs.2008.05.068. 19154907
   Web of Science ®Google Scholar
• Yankah C A, Pasic M, Musci M, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years. The Journal of Thoracic and Cardiovascular Surgery. 2008;136(3):688–696. doi:https://doi.org/10.1016/j.jtcvs.2008.05.022.
   PubMed Web of Science ®Google Scholar
• David T E, Feindel C M, Bos J, et al. Aortic valve replacement with Toronto SPV bioprosthesis: Optimal patient survival but suboptimal valve durability. The Journal of Thoracic and Cardiovascular Surgery. 2008;135(1):19–24. doi:https://doi.org/10.1016/j.jtcvs.2007.04.068.
   Web of Science ®Google Scholar
• Jamieson W E, Burr L H, Miyagishima R T, et al. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years. The Journal of Thoracic and Cardiovascular Surgery. 2005;130(4):994–1000. doi:https://doi.org/10.1016/j.jtcvs.2005.03.040.
   Web of Science ®Google Scholar
• Hickey GL, Bridgewater B, Grant SW, et al. National registry data and record linkage to inform postmarket surveillance of prosthetic aortic valve models over 15 years. JAMA Intern Med. 2017;177(1):79–86.
   PubMed Web of Science ®Google Scholar
• Gunning PS, Vaughan TJ, McNamara LM. Simulation of self expanding transcatheter aortic valve in a realistic aortic root: implications of deployment geometry on leaflet deformation. Ann Biomed Eng. 2014;42(9):1989–2001.
   PubMed Web of Science ®Google Scholar
• Khodaee F, Qiu D, Dvir D, et al. Reducing the risk of leaflet thrombosis in transcatheter aortic valve-in-valve implantation by BASILICA: a computational simulation study. EuroIntervention. 2019;15(1):67–70.
   Web of Science ®Google Scholar
• Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61(4):413–419.
   PubMed Web of Science ®Google Scholar
• Gerckens U, Tamburino C, Bleiziffer S, et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J. 2017;38(36):2729–2738.
   PubMed Web of Science ®Google Scholar
• Didier R, Eltchaninoff H, Donzeau-Gouge P, et al. Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients. Circulation. 2018;138(23):2597–2607.
   PubMed Web of Science ®Google Scholar
• Eltchaninoff H, Durand E, Avinee G, et al. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. EuroIntervention. 2018;14(3):e264–e71.
   PubMed Web of Science ®Google Scholar
• Holy EW, Kebernik J, Abdelghani M, et al. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. EuroIntervention. 2018;14(4):e390–e96.
   PubMed Web of Science ®Google Scholar
• Deutsch MA, Erlebach M, Burri M, et al. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices. EuroIntervention. 2018;14(1):41–49.
   PubMed Web of Science ®Google Scholar
• Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73(5):537–545.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, Ihlemann N, Capodanno D, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73(5):546–553.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Costa G, Zappulla P, et al. Incidence of Long‐Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2018;7(15)doi:https://doi.org/10.1161/JAHA.117.008440.
   Web of Science ®Google Scholar
• Panico R A, Giannini C, De Carlo M, et al. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention. 2019;14(16):1639–1647. doi:https://doi.org/10.4244/EIJ-D-18-00779. 30561369
   PubMed Web of Science ®Google Scholar
• Durand E, Sokoloff A, Urena-Alcazar M, et al. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition. Circ: Cardiovascular Interventions. 2019;12(4)doi:https://doi.org/10.1161/CIRCINTERVENTIONS.118.007597.
   Web of Science ®Google Scholar
• Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. European Heart Journal. 2020;41(20):1876–1886. doi:https://doi.org/10.1093/eurheartj/ehz925.
   PubMed Web of Science ®Google Scholar
• Silaschi M, Wendler O, Seiffert M, et al. Transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses. Interact CardioVasc Thorac Surg. 2017;24(1):63–70.
   Web of Science ®Google Scholar
• Salaun E, Zenses AS, Clavel MA, et al. Valve-in-valve procedure in failed transcatheter aortic valves. JACC Cardiovasc Imaging. 2019;12(1):198–202.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Frerker C, Alessandrini H, et al. Redo TAVI: initial experience at two German centres. EuroIntervention. 2016;12(7):875–882.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv. 2016;9(9):e003930.
   PubMed Web of Science ®Google Scholar